TABLE 2. Per cent (%) of baseline anti-factor VIII IgG4 remaining after preanalytical heat treatment of plasma from haemophilia patients with given Nijmegen-Bethesda units (NBU), measured by fluorescence immunoassay in median fluorescence intensity (MFI) 78.
Baseline IgG4 (MFI) |
% Remaining at 56°C After |
% Remaining at 58°C After |
||||
---|---|---|---|---|---|---|
Specimens | NBU | 30′ | 60′ | 30′ | 60′ | |
Patient A | 1.5 | 169 | 104 | 78 | 76 | 47 |
Patient B | 1.6 | 1919 | 117 | 102 | 83 | 61 |
Patient C | 19.3 | 12 596 | 91 | 92 | 100 | 75 |
Patient D | 1.6 | 16 563 | 91 | 96 | 95 | ND |
Patient E | 1.1 | 303 | 120 | 147 | 93 | 93 |
Patient F | 1.1 | 1208 | 115 | 100 | 76 | 65 |
Patient G | 0.5 | 17 194 | 80 | 93 | 72 | 39 |
Patient H | 5.4 | 22 156 | 92 | 94 | 88 | 79 |
Mean | 101 | 100 | 85* | 66* | ||
Range | 80–120 | 78–147 | 72–93 | 39–93 |
Significantly different from original level in paired t test at P < .05; ND, no data.